Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Bioavailability Study of Dimotec vs Detralex in Healthy Subjects Under Fed Conditions
NCT07674446Phase 1Recruiting
- Sponsor
- Kéri Pharma
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diosmin in chronic venous insufficiency (CVI) (2 arms), sponsored by Kéri Pharma. Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time Zero to Last Measurable Concentration at 72 hours. Started Jun 2026; status: recruiting.
02
Drugs
diosmin
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT07674446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07674446.